Abstract
Twenty-six eyes of 24 diabetic patients affected by proliferative diabetic retinopathy were randomly treated with diode (810 nm) (13 eyes) and argon-green (514 nm) lasers (13 eyes). In the diode laser group, partial or total regression of neovascularizations was observed in 9 eyes (69.2%) while 4 (30.8%) remained unchanged. In argon-green group seven eyes (53.8%) showed partial or total regression, 5 (38.2%) unchanged and 1 (7.6%) worsened. The mean follow-up time was 6.8 months (SD 2.2) for the diode laser group and 7.8 months (SD 3.2) for the argon-green laser group. The authors discuss the results and the clinical side-effects observed on the basis to the further development of the diode laser in clinical practice.
| Original language | English |
|---|---|
| Pages (from-to) | 233-237 |
| Number of pages | 5 |
| Journal | Lasers and Light in Ophthalmology |
| Volume | 3 |
| Issue number | 3 |
| Publication status | Published - 1990 |
ASJC Scopus subject areas
- Ophthalmology